Epithelial-Mesenchymal Transition, human (Scheel, 2011): : averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOSL2
|
ENSG00000075426.7 | FOSL2 |
SMARCC1
|
ENSG00000173473.6 | SMARCC1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOSL2 | hg19_v2_chr2_+_28618532_28618610 | -0.15 | 7.2e-01 | Click! |
SMARCC1 | hg19_v2_chr3_-_47823298_47823423 | -0.02 | 9.7e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr18_+_21452964 | 7.45 |
ENST00000587184.1 |
LAMA3 |
laminin, alpha 3 |
chr18_+_21452804 | 7.35 |
ENST00000269217.6 |
LAMA3 |
laminin, alpha 3 |
chr19_-_36004543 | 2.62 |
ENST00000339686.3 ENST00000447113.2 ENST00000440396.1 |
DMKN |
dermokine |
chr17_-_39769005 | 2.61 |
ENST00000301653.4 ENST00000593067.1 |
KRT16 |
keratin 16 |
chr19_-_35992780 | 2.53 |
ENST00000593342.1 ENST00000601650.1 ENST00000408915.2 |
DMKN |
dermokine |
chr15_+_41136586 | 2.14 |
ENST00000431806.1 |
SPINT1 |
serine peptidase inhibitor, Kunitz type 1 |
chr20_+_44637526 | 2.13 |
ENST00000372330.3 |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
chr18_+_61442629 | 1.85 |
ENST00000398019.2 ENST00000540675.1 |
SERPINB7 |
serpin peptidase inhibitor, clade B (ovalbumin), member 7 |
chr11_-_102668879 | 1.76 |
ENST00000315274.6 |
MMP1 |
matrix metallopeptidase 1 (interstitial collagenase) |
chr2_+_102618428 | 1.73 |
ENST00000457817.1 |
IL1R2 |
interleukin 1 receptor, type II |
chr19_-_51523412 | 1.71 |
ENST00000391805.1 ENST00000599077.1 |
KLK10 |
kallikrein-related peptidase 10 |
chr15_+_40532058 | 1.70 |
ENST00000260404.4 |
PAK6 |
p21 protein (Cdc42/Rac)-activated kinase 6 |
chr3_-_151034734 | 1.69 |
ENST00000260843.4 |
GPR87 |
G protein-coupled receptor 87 |
chr19_-_51523275 | 1.59 |
ENST00000309958.3 |
KLK10 |
kallikrein-related peptidase 10 |
chr7_+_73245193 | 1.53 |
ENST00000340958.2 |
CLDN4 |
claudin 4 |
chr11_+_394196 | 1.53 |
ENST00000331563.2 ENST00000531857.1 |
PKP3 |
plakophilin 3 |
chr16_+_57662138 | 1.44 |
ENST00000562414.1 ENST00000561969.1 ENST00000562631.1 ENST00000563445.1 ENST00000565338.1 ENST00000567702.1 |
GPR56 |
G protein-coupled receptor 56 |
chr1_-_21059029 | 1.36 |
ENST00000444387.2 ENST00000375031.1 ENST00000518294.1 |
SH2D5 |
SH2 domain containing 5 |
chr11_+_12308447 | 1.35 |
ENST00000256186.2 |
MICALCL |
MICAL C-terminal like |
chr16_+_57662419 | 1.29 |
ENST00000388812.4 ENST00000538815.1 ENST00000456916.1 ENST00000567154.1 ENST00000388813.5 ENST00000562558.1 ENST00000566271.2 |
GPR56 |
G protein-coupled receptor 56 |
chr18_+_34124507 | 1.25 |
ENST00000591635.1 |
FHOD3 |
formin homology 2 domain containing 3 |
chr15_+_41136216 | 1.22 |
ENST00000562057.1 ENST00000344051.4 |
SPINT1 |
serine peptidase inhibitor, Kunitz type 1 |
chr1_+_183155373 | 1.19 |
ENST00000493293.1 ENST00000264144.4 |
LAMC2 |
laminin, gamma 2 |
chr1_+_35220613 | 1.16 |
ENST00000338513.1 |
GJB5 |
gap junction protein, beta 5, 31.1kDa |
chr12_-_53343602 | 1.12 |
ENST00000546897.1 ENST00000552551.1 |
KRT8 |
keratin 8 |
chr11_+_10476851 | 1.09 |
ENST00000396553.2 |
AMPD3 |
adenosine monophosphate deaminase 3 |
chr12_-_52845910 | 1.07 |
ENST00000252252.3 |
KRT6B |
keratin 6B |
chr11_-_108408895 | 0.98 |
ENST00000443411.1 ENST00000533052.1 |
EXPH5 |
exophilin 5 |
chr19_+_39279838 | 0.96 |
ENST00000314980.4 |
LGALS7B |
lectin, galactoside-binding, soluble, 7B |
chr2_+_113875466 | 0.92 |
ENST00000361779.3 ENST00000259206.5 ENST00000354115.2 |
IL1RN |
interleukin 1 receptor antagonist |
chr15_+_40531243 | 0.92 |
ENST00000558055.1 ENST00000455577.2 |
PAK6 |
p21 protein (Cdc42/Rac)-activated kinase 6 |
chr11_-_118134997 | 0.92 |
ENST00000278937.2 |
MPZL2 |
myelin protein zero-like 2 |
chr19_-_51504411 | 0.91 |
ENST00000593490.1 |
KLK8 |
kallikrein-related peptidase 8 |
chr2_-_113542063 | 0.91 |
ENST00000263339.3 |
IL1A |
interleukin 1, alpha |
chr15_+_40531621 | 0.88 |
ENST00000560346.1 |
PAK6 |
p21 protein (Cdc42/Rac)-activated kinase 6 |
chr10_+_24755416 | 0.87 |
ENST00000396446.1 ENST00000396445.1 ENST00000376451.2 |
KIAA1217 |
KIAA1217 |
chr19_-_44174330 | 0.85 |
ENST00000340093.3 |
PLAUR |
plasminogen activator, urokinase receptor |
chr17_+_55162453 | 0.82 |
ENST00000575322.1 ENST00000337714.3 ENST00000314126.3 |
AKAP1 |
A kinase (PRKA) anchor protein 1 |
chr18_+_61445007 | 0.82 |
ENST00000447428.1 ENST00000546027.1 |
SERPINB7 |
serpin peptidase inhibitor, clade B (ovalbumin), member 7 |
chr3_-_98241358 | 0.81 |
ENST00000503004.1 ENST00000506575.1 ENST00000513452.1 ENST00000515620.1 |
CLDND1 |
claudin domain containing 1 |
chr1_+_15256230 | 0.79 |
ENST00000376028.4 ENST00000400798.2 |
KAZN |
kazrin, periplakin interacting protein |
chr12_-_95009837 | 0.78 |
ENST00000551457.1 |
TMCC3 |
transmembrane and coiled-coil domain family 3 |
chr19_-_44174305 | 0.77 |
ENST00000601723.1 ENST00000339082.3 |
PLAUR |
plasminogen activator, urokinase receptor |
chr8_+_120220561 | 0.77 |
ENST00000276681.6 |
MAL2 |
mal, T-cell differentiation protein 2 (gene/pseudogene) |
chr6_+_47666275 | 0.75 |
ENST00000327753.3 ENST00000283303.2 |
GPR115 |
G protein-coupled receptor 115 |
chr11_-_118135160 | 0.74 |
ENST00000438295.2 |
MPZL2 |
myelin protein zero-like 2 |
chr12_-_95510743 | 0.73 |
ENST00000551521.1 |
FGD6 |
FYVE, RhoGEF and PH domain containing 6 |
chr1_-_153521714 | 0.73 |
ENST00000368713.3 |
S100A3 |
S100 calcium binding protein A3 |
chr1_-_153521597 | 0.73 |
ENST00000368712.1 |
S100A3 |
S100 calcium binding protein A3 |
chr7_+_26331541 | 0.71 |
ENST00000416246.1 ENST00000338523.4 ENST00000412416.1 |
SNX10 |
sorting nexin 10 |
chr6_+_41604747 | 0.71 |
ENST00000419164.1 ENST00000373051.2 |
MDFI |
MyoD family inhibitor |
chr4_-_36246060 | 0.70 |
ENST00000303965.4 |
ARAP2 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
chr8_+_82644669 | 0.70 |
ENST00000297265.4 |
CHMP4C |
charged multivesicular body protein 4C |
chr3_-_12800751 | 0.69 |
ENST00000435218.2 ENST00000435575.1 |
TMEM40 |
transmembrane protein 40 |
chr17_-_7493390 | 0.68 |
ENST00000538513.2 ENST00000570788.1 ENST00000250055.2 |
SOX15 |
SRY (sex determining region Y)-box 15 |
chr18_-_74207146 | 0.68 |
ENST00000443185.2 |
ZNF516 |
zinc finger protein 516 |
chr6_+_47624172 | 0.66 |
ENST00000507065.1 ENST00000296862.1 |
GPR111 |
G protein-coupled receptor 111 |
chr1_+_2004901 | 0.64 |
ENST00000400921.2 |
PRKCZ |
protein kinase C, zeta |
chr19_-_39264072 | 0.63 |
ENST00000599035.1 ENST00000378626.4 |
LGALS7 |
lectin, galactoside-binding, soluble, 7 |
chr17_-_27503770 | 0.63 |
ENST00000533112.1 |
MYO18A |
myosin XVIIIA |
chr1_-_156675368 | 0.63 |
ENST00000368222.3 |
CRABP2 |
cellular retinoic acid binding protein 2 |
chr2_+_220492373 | 0.61 |
ENST00000317151.3 |
SLC4A3 |
solute carrier family 4 (anion exchanger), member 3 |
chr1_+_2005425 | 0.61 |
ENST00000461106.2 |
PRKCZ |
protein kinase C, zeta |
chr1_-_28520447 | 0.61 |
ENST00000539896.1 |
PTAFR |
platelet-activating factor receptor |
chr3_+_124223586 | 0.60 |
ENST00000393496.1 |
KALRN |
kalirin, RhoGEF kinase |
chr17_+_48610074 | 0.60 |
ENST00000503690.1 ENST00000514874.1 ENST00000537145.1 ENST00000541226.1 |
EPN3 |
epsin 3 |
chr10_-_6019984 | 0.59 |
ENST00000525219.2 |
IL15RA |
interleukin 15 receptor, alpha |
chr14_+_96722539 | 0.58 |
ENST00000553356.1 |
BDKRB1 |
bradykinin receptor B1 |
chr12_+_56473628 | 0.57 |
ENST00000549282.1 ENST00000549061.1 ENST00000267101.3 |
ERBB3 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 |
chr11_+_62649158 | 0.56 |
ENST00000539891.1 ENST00000536981.1 |
SLC3A2 |
solute carrier family 3 (amino acid transporter heavy chain), member 2 |
chr1_-_6662919 | 0.56 |
ENST00000377658.4 ENST00000377663.3 |
KLHL21 |
kelch-like family member 21 |
chr2_-_113594279 | 0.56 |
ENST00000416750.1 ENST00000418817.1 ENST00000263341.2 |
IL1B |
interleukin 1, beta |
chr9_+_35673853 | 0.55 |
ENST00000378357.4 |
CA9 |
carbonic anhydrase IX |
chr16_+_30751953 | 0.55 |
ENST00000483578.1 |
RP11-2C24.4 |
RP11-2C24.4 |
chr17_+_30771279 | 0.55 |
ENST00000261712.3 ENST00000578213.1 ENST00000457654.2 ENST00000579451.1 |
PSMD11 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 |
chr10_-_6019552 | 0.55 |
ENST00000379977.3 ENST00000397251.3 ENST00000397248.2 |
IL15RA |
interleukin 15 receptor, alpha |
chr1_-_209824643 | 0.55 |
ENST00000391911.1 ENST00000415782.1 |
LAMB3 |
laminin, beta 3 |
chr1_-_28520384 | 0.54 |
ENST00000305392.3 |
PTAFR |
platelet-activating factor receptor |
chr13_-_86373536 | 0.54 |
ENST00000400286.2 |
SLITRK6 |
SLIT and NTRK-like family, member 6 |
chr1_-_153029980 | 0.54 |
ENST00000392653.2 |
SPRR2A |
small proline-rich protein 2A |
chr19_-_36019123 | 0.48 |
ENST00000588674.1 ENST00000452271.2 ENST00000518157.1 |
SBSN |
suprabasin |
chr18_+_61254570 | 0.47 |
ENST00000344731.5 |
SERPINB13 |
serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
chr2_-_238499303 | 0.47 |
ENST00000409576.1 |
RAB17 |
RAB17, member RAS oncogene family |
chr4_+_76481258 | 0.46 |
ENST00000311623.4 ENST00000435974.2 |
C4orf26 |
chromosome 4 open reading frame 26 |
chr6_+_30852130 | 0.46 |
ENST00000428153.2 ENST00000376568.3 ENST00000452441.1 ENST00000515219.1 |
DDR1 |
discoidin domain receptor tyrosine kinase 1 |
chr22_+_45072925 | 0.46 |
ENST00000006251.7 |
PRR5 |
proline rich 5 (renal) |
chr22_+_45072958 | 0.46 |
ENST00000403581.1 |
PRR5 |
proline rich 5 (renal) |
chr14_+_96722152 | 0.44 |
ENST00000216629.6 |
BDKRB1 |
bradykinin receptor B1 |
chr6_+_106546808 | 0.44 |
ENST00000369089.3 |
PRDM1 |
PR domain containing 1, with ZNF domain |
chr15_+_89182178 | 0.44 |
ENST00000559876.1 |
ISG20 |
interferon stimulated exonuclease gene 20kDa |
chr11_-_75201791 | 0.43 |
ENST00000529721.1 |
GDPD5 |
glycerophosphodiester phosphodiesterase domain containing 5 |
chr15_+_89181974 | 0.43 |
ENST00000306072.5 |
ISG20 |
interferon stimulated exonuclease gene 20kDa |
chr6_+_44194762 | 0.41 |
ENST00000371708.1 |
SLC29A1 |
solute carrier family 29 (equilibrative nucleoside transporter), member 1 |
chr7_-_20256965 | 0.41 |
ENST00000400331.5 ENST00000332878.4 |
MACC1 |
metastasis associated in colon cancer 1 |
chrX_-_33229636 | 0.41 |
ENST00000357033.4 |
DMD |
dystrophin |
chr13_+_78109804 | 0.41 |
ENST00000535157.1 |
SCEL |
sciellin |
chr13_+_78109884 | 0.40 |
ENST00000377246.3 ENST00000349847.3 |
SCEL |
sciellin |
chr1_-_43751230 | 0.40 |
ENST00000523677.1 |
C1orf210 |
chromosome 1 open reading frame 210 |
chr19_-_35981358 | 0.40 |
ENST00000484218.2 ENST00000338897.3 |
KRTDAP |
keratinocyte differentiation-associated protein |
chr14_+_21510385 | 0.40 |
ENST00000298690.4 |
RNASE7 |
ribonuclease, RNase A family, 7 |
chr10_+_75670862 | 0.39 |
ENST00000446342.1 ENST00000372764.3 ENST00000372762.4 |
PLAU |
plasminogen activator, urokinase |
chr8_+_124780672 | 0.39 |
ENST00000521166.1 ENST00000334705.7 |
FAM91A1 |
family with sequence similarity 91, member A1 |
chr16_+_22308717 | 0.39 |
ENST00000299853.5 ENST00000564209.1 ENST00000565358.1 ENST00000418581.2 ENST00000564883.1 ENST00000359210.4 ENST00000563024.1 |
POLR3E |
polymerase (RNA) III (DNA directed) polypeptide E (80kD) |
chr20_+_48909240 | 0.39 |
ENST00000371639.3 |
RP11-290F20.1 |
RP11-290F20.1 |
chr9_-_23826298 | 0.39 |
ENST00000380117.1 |
ELAVL2 |
ELAV like neuron-specific RNA binding protein 2 |
chr9_-_124991124 | 0.39 |
ENST00000394319.4 ENST00000340587.3 |
LHX6 |
LIM homeobox 6 |
chr19_+_7953384 | 0.38 |
ENST00000306708.6 |
LRRC8E |
leucine rich repeat containing 8 family, member E |
chr17_-_39942940 | 0.38 |
ENST00000310706.5 ENST00000393931.3 ENST00000424457.1 ENST00000591690.1 |
JUP |
junction plakoglobin |
chr17_-_8021710 | 0.38 |
ENST00000380149.1 ENST00000448843.2 |
ALOXE3 |
arachidonate lipoxygenase 3 |
chr6_-_138428613 | 0.38 |
ENST00000421351.3 |
PERP |
PERP, TP53 apoptosis effector |
chr2_+_86668464 | 0.38 |
ENST00000409064.1 |
KDM3A |
lysine (K)-specific demethylase 3A |
chr2_-_238499131 | 0.38 |
ENST00000538644.1 |
RAB17 |
RAB17, member RAS oncogene family |
chr15_+_89182156 | 0.38 |
ENST00000379224.5 |
ISG20 |
interferon stimulated exonuclease gene 20kDa |
chr2_-_238499337 | 0.37 |
ENST00000411462.1 ENST00000409822.1 |
RAB17 |
RAB17, member RAS oncogene family |
chr11_+_1856034 | 0.36 |
ENST00000341958.3 |
SYT8 |
synaptotagmin VIII |
chr17_+_73717407 | 0.35 |
ENST00000579662.1 |
ITGB4 |
integrin, beta 4 |
chr3_-_122512619 | 0.35 |
ENST00000383659.1 ENST00000306103.2 |
HSPBAP1 |
HSPB (heat shock 27kDa) associated protein 1 |
chrX_-_15683147 | 0.34 |
ENST00000380342.3 |
TMEM27 |
transmembrane protein 27 |
chr17_+_73717551 | 0.34 |
ENST00000450894.3 |
ITGB4 |
integrin, beta 4 |
chr5_+_145316120 | 0.34 |
ENST00000359120.4 |
SH3RF2 |
SH3 domain containing ring finger 2 |
chr5_+_150020214 | 0.34 |
ENST00000307662.4 |
SYNPO |
synaptopodin |
chr11_+_1855645 | 0.34 |
ENST00000381968.3 ENST00000381978.3 |
SYT8 |
synaptotagmin VIII |
chr10_+_104155450 | 0.33 |
ENST00000471698.1 ENST00000189444.6 |
NFKB2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
chr4_+_84457250 | 0.33 |
ENST00000395226.2 |
AGPAT9 |
1-acylglycerol-3-phosphate O-acyltransferase 9 |
chr1_-_153113927 | 0.33 |
ENST00000368752.4 |
SPRR2B |
small proline-rich protein 2B |
chrX_-_24665208 | 0.33 |
ENST00000356768.4 |
PCYT1B |
phosphate cytidylyltransferase 1, choline, beta |
chrX_-_154563889 | 0.32 |
ENST00000369449.2 ENST00000321926.4 |
CLIC2 |
chloride intracellular channel 2 |
chr17_+_21191341 | 0.32 |
ENST00000526076.2 ENST00000361818.5 ENST00000316920.6 |
MAP2K3 |
mitogen-activated protein kinase kinase 3 |
chr11_+_128563652 | 0.32 |
ENST00000527786.2 |
FLI1 |
Fli-1 proto-oncogene, ETS transcription factor |
chr6_-_30712313 | 0.32 |
ENST00000376377.2 ENST00000259874.5 |
IER3 |
immediate early response 3 |
chr3_+_36421826 | 0.32 |
ENST00000273183.3 |
STAC |
SH3 and cysteine rich domain |
chr19_-_51472823 | 0.32 |
ENST00000310157.2 |
KLK6 |
kallikrein-related peptidase 6 |
chr4_+_84457529 | 0.32 |
ENST00000264409.4 |
AGPAT9 |
1-acylglycerol-3-phosphate O-acyltransferase 9 |
chr15_-_44486632 | 0.32 |
ENST00000484674.1 |
FRMD5 |
FERM domain containing 5 |
chr19_+_15052301 | 0.31 |
ENST00000248072.3 |
OR7C2 |
olfactory receptor, family 7, subfamily C, member 2 |
chr1_+_36621697 | 0.31 |
ENST00000373150.4 ENST00000373151.2 |
MAP7D1 |
MAP7 domain containing 1 |
chr2_-_64371546 | 0.30 |
ENST00000358912.4 |
PELI1 |
pellino E3 ubiquitin protein ligase 1 |
chr17_-_39743139 | 0.30 |
ENST00000167586.6 |
KRT14 |
keratin 14 |
chr16_-_30125177 | 0.30 |
ENST00000406256.3 |
GDPD3 |
glycerophosphodiester phosphodiesterase domain containing 3 |
chr5_+_35856951 | 0.30 |
ENST00000303115.3 ENST00000343305.4 ENST00000506850.1 ENST00000511982.1 |
IL7R |
interleukin 7 receptor |
chr6_+_32121218 | 0.29 |
ENST00000414204.1 ENST00000361568.2 ENST00000395523.1 |
PPT2 |
palmitoyl-protein thioesterase 2 |
chr6_+_151042224 | 0.29 |
ENST00000358517.2 |
PLEKHG1 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 1 |
chr5_-_78809950 | 0.28 |
ENST00000334082.6 |
HOMER1 |
homer homolog 1 (Drosophila) |
chr4_+_108745711 | 0.28 |
ENST00000394684.4 |
SGMS2 |
sphingomyelin synthase 2 |
chr10_-_6019455 | 0.27 |
ENST00000530685.1 ENST00000397255.3 ENST00000379971.1 ENST00000528354.1 ENST00000397250.2 ENST00000429135.2 |
IL15RA |
interleukin 15 receptor, alpha |
chr1_-_9970227 | 0.27 |
ENST00000377263.1 |
CTNNBIP1 |
catenin, beta interacting protein 1 |
chr12_+_56732658 | 0.26 |
ENST00000228534.4 |
IL23A |
interleukin 23, alpha subunit p19 |
chr18_-_35065710 | 0.26 |
ENST00000589229.1 ENST00000587819.1 |
CELF4 |
CUGBP, Elav-like family member 4 |
chr8_-_141774467 | 0.26 |
ENST00000520151.1 ENST00000519024.1 ENST00000519465.1 |
PTK2 |
protein tyrosine kinase 2 |
chr22_-_37584321 | 0.26 |
ENST00000397110.2 ENST00000337843.2 |
C1QTNF6 |
C1q and tumor necrosis factor related protein 6 |
chr11_+_66742742 | 0.26 |
ENST00000308963.4 |
C11orf86 |
chromosome 11 open reading frame 86 |
chr19_+_36203830 | 0.26 |
ENST00000262630.3 |
ZBTB32 |
zinc finger and BTB domain containing 32 |
chr6_+_31082603 | 0.25 |
ENST00000259881.9 |
PSORS1C1 |
psoriasis susceptibility 1 candidate 1 |
chrX_-_24665353 | 0.25 |
ENST00000379144.2 |
PCYT1B |
phosphate cytidylyltransferase 1, choline, beta |
chr6_+_138188551 | 0.25 |
ENST00000237289.4 ENST00000433680.1 |
TNFAIP3 |
tumor necrosis factor, alpha-induced protein 3 |
chr20_-_1309809 | 0.25 |
ENST00000360779.3 |
SDCBP2 |
syndecan binding protein (syntenin) 2 |
chr17_+_35851570 | 0.25 |
ENST00000394386.1 |
DUSP14 |
dual specificity phosphatase 14 |
chr5_+_135394840 | 0.24 |
ENST00000503087.1 |
TGFBI |
transforming growth factor, beta-induced, 68kDa |
chr7_+_48128194 | 0.24 |
ENST00000416681.1 ENST00000331803.4 ENST00000432131.1 |
UPP1 |
uridine phosphorylase 1 |
chr7_+_48128316 | 0.24 |
ENST00000341253.4 |
UPP1 |
uridine phosphorylase 1 |
chr11_+_128563948 | 0.24 |
ENST00000534087.2 |
FLI1 |
Fli-1 proto-oncogene, ETS transcription factor |
chr5_-_134914673 | 0.24 |
ENST00000512158.1 |
CXCL14 |
chemokine (C-X-C motif) ligand 14 |
chr12_-_95044309 | 0.24 |
ENST00000261226.4 |
TMCC3 |
transmembrane and coiled-coil domain family 3 |
chr17_+_73717516 | 0.24 |
ENST00000200181.3 ENST00000339591.3 |
ITGB4 |
integrin, beta 4 |
chr12_+_9144626 | 0.24 |
ENST00000543895.1 |
KLRG1 |
killer cell lectin-like receptor subfamily G, member 1 |
chr10_-_129691195 | 0.24 |
ENST00000368671.3 |
CLRN3 |
clarin 3 |
chr1_+_161692449 | 0.23 |
ENST00000367946.3 ENST00000367945.1 ENST00000336830.5 ENST00000367944.3 ENST00000392158.1 |
FCRLB |
Fc receptor-like B |
chr11_+_59522837 | 0.22 |
ENST00000437946.2 |
STX3 |
syntaxin 3 |
chr17_-_41623075 | 0.22 |
ENST00000545089.1 |
ETV4 |
ets variant 4 |
chr1_+_27189631 | 0.22 |
ENST00000339276.4 |
SFN |
stratifin |
chr13_-_36429763 | 0.21 |
ENST00000379893.1 |
DCLK1 |
doublecortin-like kinase 1 |
chr11_-_47207390 | 0.21 |
ENST00000539589.1 ENST00000528462.1 |
PACSIN3 |
protein kinase C and casein kinase substrate in neurons 3 |
chr17_+_78075361 | 0.21 |
ENST00000577106.1 ENST00000390015.3 |
GAA |
glucosidase, alpha; acid |
chr18_-_53253323 | 0.21 |
ENST00000540999.1 ENST00000563888.2 |
TCF4 |
transcription factor 4 |
chr2_+_220306745 | 0.21 |
ENST00000431523.1 ENST00000396698.1 ENST00000396695.2 |
SPEG |
SPEG complex locus |
chr2_+_89998789 | 0.20 |
ENST00000453166.2 |
IGKV2D-28 |
immunoglobulin kappa variable 2D-28 |
chr5_+_141016969 | 0.20 |
ENST00000518856.1 |
RELL2 |
RELT-like 2 |
chr4_-_170947485 | 0.20 |
ENST00000504999.1 |
MFAP3L |
microfibrillar-associated protein 3-like |
chr19_+_17865011 | 0.20 |
ENST00000596462.1 ENST00000596865.1 ENST00000598960.1 ENST00000539407.1 |
FCHO1 |
FCH domain only 1 |
chr6_-_29324054 | 0.20 |
ENST00000543825.1 |
OR5V1 |
olfactory receptor, family 5, subfamily V, member 1 |
chr3_+_160394940 | 0.20 |
ENST00000320767.2 |
ARL14 |
ADP-ribosylation factor-like 14 |
chr22_+_21987005 | 0.20 |
ENST00000607942.1 ENST00000425975.1 ENST00000292779.3 |
CCDC116 |
coiled-coil domain containing 116 |
chr6_-_35888905 | 0.19 |
ENST00000510290.1 ENST00000423325.2 ENST00000373822.1 |
SRPK1 |
SRSF protein kinase 1 |
chr13_+_80055581 | 0.19 |
ENST00000487865.1 |
NDFIP2 |
Nedd4 family interacting protein 2 |
chr6_-_35888824 | 0.19 |
ENST00000361690.3 ENST00000512445.1 |
SRPK1 |
SRSF protein kinase 1 |
chr2_-_89521942 | 0.19 |
ENST00000482769.1 |
IGKV2-28 |
immunoglobulin kappa variable 2-28 |
chr17_-_41623259 | 0.19 |
ENST00000538265.1 ENST00000591713.1 |
ETV4 |
ets variant 4 |
chr18_-_53253112 | 0.19 |
ENST00000568673.1 ENST00000562847.1 ENST00000568147.1 |
TCF4 |
transcription factor 4 |
chr17_+_78075498 | 0.19 |
ENST00000302262.3 |
GAA |
glucosidase, alpha; acid |
chr8_-_143851203 | 0.19 |
ENST00000521396.1 ENST00000317543.7 |
LYNX1 |
Ly6/neurotoxin 1 |
chr16_+_28996364 | 0.19 |
ENST00000564277.1 |
LAT |
linker for activation of T cells |
chr3_+_184037466 | 0.18 |
ENST00000441154.1 |
EIF4G1 |
eukaryotic translation initiation factor 4 gamma, 1 |
chr2_+_89923550 | 0.18 |
ENST00000509129.1 |
IGKV1D-37 |
immunoglobulin kappa variable 1D-37 (non-functional) |
chr4_-_76944621 | 0.18 |
ENST00000306602.1 |
CXCL10 |
chemokine (C-X-C motif) ligand 10 |
chr1_+_36621529 | 0.18 |
ENST00000316156.4 |
MAP7D1 |
MAP7 domain containing 1 |
chr6_-_44233361 | 0.18 |
ENST00000275015.5 |
NFKBIE |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
chr6_+_33043703 | 0.18 |
ENST00000418931.2 ENST00000535465.1 |
HLA-DPB1 |
major histocompatibility complex, class II, DP beta 1 |
chr22_+_22781853 | 0.18 |
ENST00000390300.2 |
IGLV5-37 |
immunoglobulin lambda variable 5-37 |
chr2_-_166651191 | 0.18 |
ENST00000392701.3 |
GALNT3 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
chr16_-_2908155 | 0.18 |
ENST00000571228.1 ENST00000161006.3 |
PRSS22 |
protease, serine, 22 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 5.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.7 | 2.7 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.6 | 17.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 1.7 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.4 | 3.8 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.4 | 1.2 | GO:1904317 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.4 | 1.9 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 1.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 1.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 1.2 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.2 | 0.7 | GO:0048627 | myoblast development(GO:0048627) |
0.2 | 0.6 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.2 | 0.4 | GO:0051302 | regulation of cell division(GO:0051302) |
0.2 | 0.6 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.2 | 1.1 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.2 | 1.3 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 3.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 0.8 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.2 | 4.6 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.7 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.4 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.9 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.5 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.1 | 0.6 | GO:0060356 | leucine import(GO:0060356) |
0.1 | 0.4 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.1 | 0.4 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.1 | 0.3 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.1 | 0.3 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.1 | 0.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.3 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.1 | 0.4 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
0.1 | 0.6 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.1 | 1.0 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 0.3 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.1 | 0.4 | GO:0015862 | uridine transport(GO:0015862) |
0.1 | 1.7 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 1.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 1.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.3 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 0.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.4 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.3 | GO:0035937 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
0.1 | 0.2 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.1 | 0.2 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.1 | 0.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.5 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.1 | 0.4 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.2 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.1 | 0.8 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.2 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
0.1 | 0.4 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.1 | 0.2 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.1 | 0.2 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.4 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
0.0 | 0.6 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.7 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.1 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.0 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.3 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.1 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) regulation of dendritic cell dendrite assembly(GO:2000547) |
0.0 | 0.2 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.0 | 0.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.3 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.0 | 0.2 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.0 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.0 | 0.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.2 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.0 | 0.4 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.0 | 0.3 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.0 | 0.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.0 | 0.2 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.0 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.4 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.0 | 0.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.1 | GO:0014806 | negative regulation of muscle hyperplasia(GO:0014740) smooth muscle hyperplasia(GO:0014806) |
0.0 | 0.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.4 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.0 | 0.1 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.0 | 0.1 | GO:0021700 | developmental maturation(GO:0021700) |
0.0 | 0.3 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.1 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.0 | 0.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.4 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.9 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.3 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.0 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.0 | 0.1 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
0.0 | 1.3 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 0.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.0 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.3 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.0 | 0.1 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
0.0 | 0.1 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.0 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 0.1 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.0 | 0.6 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.0 | 0.1 | GO:0070384 | Harderian gland development(GO:0070384) |
0.0 | 0.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.1 | GO:1901091 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.0 | 0.1 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.1 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.0 | 0.1 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.0 | 0.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.0 | 0.1 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.0 | 0.1 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.0 | 0.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.1 | GO:0003231 | cardiac ventricle development(GO:0003231) |
0.0 | 0.1 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.1 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.0 | 0.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 0.9 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.0 | GO:0046959 | habituation(GO:0046959) |
0.0 | 0.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.0 | 0.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.1 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.0 | 0.0 | GO:0072240 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
0.0 | 0.0 | GO:0072017 | distal tubule development(GO:0072017) |
0.0 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.8 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.0 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.0 | 0.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.1 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.0 | 0.1 | GO:0007619 | courtship behavior(GO:0007619) |
0.0 | 0.1 | GO:0043542 | endothelial cell migration(GO:0043542) |
0.0 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.1 | GO:1903401 | L-lysine transmembrane transport(GO:1903401) |
0.0 | 0.1 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
0.0 | 0.2 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.1 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.0 | 0.0 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.0 | 0.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.0 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.0 | 0.1 | GO:0032438 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.0 | 0.1 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 15.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.4 | 1.2 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.1 | 0.3 | GO:0097444 | spine apparatus(GO:0097444) |
0.1 | 0.4 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.1 | 1.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 1.3 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 3.2 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 2.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 0.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.3 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.2 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.0 | 1.2 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.0 | 1.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 1.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.4 | GO:0016013 | syntrophin complex(GO:0016013) |
0.0 | 0.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.3 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.0 | 0.1 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.0 | 0.1 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
0.0 | 1.6 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.1 | GO:0031251 | PAN complex(GO:0031251) |
0.0 | 0.1 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.0 | 0.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 1.2 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 3.1 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.1 | GO:0097513 | myosin II filament(GO:0097513) |
0.0 | 1.8 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.8 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.6 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.4 | 1.2 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.3 | 1.7 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.3 | 1.0 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.3 | 0.9 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.1 | 0.4 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 0.4 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.1 | 1.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 1.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 1.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 1.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.5 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.1 | 0.4 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.1 | 0.5 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.1 | 1.7 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.3 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.1 | 1.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.1 | 1.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.3 | GO:0070026 | nitric oxide binding(GO:0070026) |
0.1 | 0.3 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 0.2 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.1 | 0.2 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 0.2 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.1 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.4 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 5.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.3 | GO:0042835 | BRE binding(GO:0042835) |
0.0 | 0.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.0 | 3.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.4 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.0 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.6 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.0 | 0.5 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.4 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 1.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.1 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.0 | 0.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.2 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.0 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.0 | 0.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.1 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.0 | 0.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.0 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.0 | 0.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 15.6 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.1 | GO:0001093 | TFIIB-class transcription factor binding(GO:0001093) |
0.0 | 4.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.1 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.0 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 1.0 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.6 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.0 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) sulfonylurea receptor binding(GO:0017098) pyrimidine ribonucleoside binding(GO:0032551) |
0.0 | 0.0 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.0 | 0.1 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.0 | 0.0 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 17.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 4.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 2.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 2.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 3.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 1.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 18.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 3.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 2.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 3.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 1.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 1.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.3 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 1.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |